<DOC>
	<DOC>NCT02397967</DOC>
	<brief_summary>A national, multicenter, randomized, transverse clinical trial, estimating the existence of phonological deficits in children with NF1 children compared with control children without NF1 with the same reading level.</brief_summary>
	<brief_title>Reading Disability in Children With NF1</brief_title>
	<detailed_description>To determine the phonological and visio -spatial performances at the NF1 children.</detailed_description>
	<mesh_term>Neurofibromatoses</mesh_term>
	<mesh_term>Neurofibroma</mesh_term>
	<mesh_term>Neurofibromatosis 1</mesh_term>
	<mesh_term>Dyslexia</mesh_term>
	<criteria>Age included between 8 and 12 years Child presenting a type 1 neurofibromatosis according to 2 criteria in the following criteria list : At least 6 caf√© au lait spots 2 or more neurofibromas or 1 plexiform neurofibroma axillary or inguinal freckling 1 optic nerf glioma 2 or more Lisch nodules 1 osseous lesion as sphenoid dysplasia or thinning of the long bone cortex with or without pseudoarthrosis 1 A first degree relative (parent, sibling, or offspring) with NF1 by the above criteria Membership in a national insurance Consent of the child and the parents Mental retardation (QI T &lt; 70) Treated or untreated epilepsy Visual deficit (visual Acuteness &lt; 4/10 Presence of a symptomatic optic glioma Presence of a brain tumor.</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>NF1</keyword>
	<keyword>children</keyword>
	<keyword>reading disabilities</keyword>
</DOC>